Literature DB >> 6773421

Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.

J Russo, I H Russo.   

Abstract

In the rat, pregnancy and lactation prior to carcinogen administration protect the mammary gland from developing carcinomas and benign lesions. In this study, the influence of pregnancy interruption versus full pregnancy and pregnancy plus lactation on the incidence of carcinomas and benign lesions was studied in the mammary glands of rats treated with 7,12-dimethylbenz(a)anthracene (DMBA). Fifty-nine Sprague-Dawley rats were separated into 5 groups: I) rats that had had one pregnancy and one lactation; II) rats that had had one pregnancy without lactation; III) rats that had had pregnancy interrupted at the 12th day of gestation; IV) age-matched virgin rats as a control Group I; and V) age-matched virgin rats as a control for groups II and III. The 5 groups received a single intragastric dose of DMBA (10 mg/100 g body weight), with the exception of 2 animals per group, which were killed 1 hour after an intraperitoneal injection of 2.5 mu Ci 3H-thymidine/g body weight. The number of labeled nuclei per 100 cells (DNA labeling index, LI) was counted in terminal end buds (TEBs), terminal ducts (TDs), and alveolar buds (ABs) of the glands. The number of structures and the DNA-LI were correlated with the incidence of tumors at 22 weeks after DMBA. Pregnancy, with or without lactation, resulted in elimination of TEBs and reduction in the DNA-LI of TDs and ABs. These groups did not develop carcinomas. After the interruption of pregnancy the mammary gland contained numerous TEBs, with a high DNA-LI; 77% of these animals developed carcinomas, and all of them developed benign lesions. Therefore, while pregnancy and lactation protected the mammary gland from developing carcinomas and benign lesions by induction of full differentiation, pregnancy interruption did not elicit sufficient differentiation in the gland to be protective, and these animals were at the same risk as virgin animals treated with the carcinogen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773421      PMCID: PMC1903536     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis.

Authors:  J Russo; I H Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

2.  CRITICAL SIGNIFICANCE OF BREAST STRUCTURE IN THE INDUCTION OF MAMMARY CANCER IN THE RAT.

Authors:  C Huggins; L C Grand; F P Brillantes
Journal:  Proc Natl Acad Sci U S A       Date:  1959-08       Impact factor: 11.205

3.  Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs.

Authors:  G S Kledzik; C J Bradley; J Meites
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

4.  Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat.

Authors:  G M McCormick; R C Moon
Journal:  Eur J Cancer       Date:  1973-07       Impact factor: 9.162

5.  Epidemiologic characteristics of cancer of the breast in Taiwan.

Authors:  T M Lin; K P Chen; B MacMahon
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

6.  Relationship between previous reproductive history and chemically induced mammary cancer in rats.

Authors:  R C Moon
Journal:  Int J Cancer       Date:  1969-05-15       Impact factor: 7.396

7.  Epidemiologic features of breast cancer in Slovenia, 1965-1967.

Authors:  B Ravnihar; B MacMahon; J Lindtner
Journal:  Eur J Cancer       Date:  1971-08       Impact factor: 9.162

8.  Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.

Authors:  I H Russo; J Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

9.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

10.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

View more
  48 in total

Review 1.  Hormone-induced protection against breast cancer.

Authors:  Lakshmi Sivaraman; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 2.  Induced abortion as cancer risk factor: a review of epidemiological evidence.

Authors:  L I Remennick
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

3.  The human breast and the ancestral reproductive cycle : A preliminary inquiry into breast cancer etiology.

Authors:  K Coe; L B Steadman
Journal:  Hum Nat       Date:  1995-09

4.  Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis.

Authors:  J Brind; V M Chinchilli; W B Severs; J Summy-Long
Journal:  J Epidemiol Community Health       Date:  1996-10       Impact factor: 3.710

5.  Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Authors:  Robert K Dearth; Jill K Hiney; Vinod K Srivastava; Alina M Hamilton; William L Dees
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-20

6.  Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.

Authors:  I H Russo; J Frederick; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

7.  p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Authors:  L Sivaraman; O M Conneely; D Medina; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  Prepubertal exposure to arsenic(III) suppresses circulating insulin-like growth factor-1 (IGF-1) delaying sexual maturation in female rats.

Authors:  Michael P Reilly; James C Saca; Alina Hamilton; Rene F Solano; Jesse R Rivera; Wendy Whitehouse-Innis; Jason G Parsons; Robert K Dearth
Journal:  Reprod Toxicol       Date:  2013-09-30       Impact factor: 3.143

9.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

10.  Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer.

Authors:  Stefan K Siwko; Jie Dong; Michael T Lewis; Hao Liu; Susan G Hilsenbeck; Yi Li
Journal:  Stem Cells       Date:  2008-09-11       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.